£1 Billion Boost for UK Life Sciences
New funding is available for the UK’s most promising life sciences companies, with the potential to crowd in further funding from other investors…
New funding is available for the UK’s most promising life sciences companies, with the potential to crowd in further funding from other investors…
To be credible and investible, ESG is becoming critical to the fund manager’s perspective, as investors shift further to sustainable investment.
Jonathan Tobin, Managing Director of Arix, talks to Vox Markets
Start planning early for the Virtual J.P. Morgan Healthcare Conference (“JPM”)
This year, in collaboration with Dechert, we held a virtual version of our leading Annual Healthcare Investor Conference on the 8th of October. The 12th event discussed how life sciences innovation is driving change – from the myriad international efforts against Covid-19 to how we communicate with the investment community. The virtue of virtual was […]